TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/14/23 16:00 | 7/12/23 | TSHA | Taysha Gene Therapies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Session R.A. II | TX | T | S.m | -61 | 0.7077 | 0 | -86 | -1 | 9,154 | D | |||||||||||||||
6/26/23 16:46 | 6/22/23 | TSHA | Taysha Gene Therapies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Session R.A. II | TX | T | S.m | -20 | 0.7033 | 0 | -29 | 0 | 9,240 | D | |||||||||||||||
6/22/23 16:00 | 6/20/23 | TSHA | Taysha Gene Therapies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Session R.A. II | TX | T | S.m | -308 | 0.7083 | 0 | -435 | -4 | 9,268 | D | |||||||||||||||
12/8/21 16:05 | 11/23/21 | TSHA | Taysha Gene Therapies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Session R.A. II | TX | DOT | P,CEO | P | 529 | 12.44 | 0 | 43 | 0 | 9,473 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |